The data were consistent with the above role of YOD1 in vitro, as manifested by the smaller tumor volume, a lower rate of tumor growth, and lighter tumor weight in YOD1 knockdown group, compared with the control group (Fig. 7B C). The gene discussed is YOD1; the disease is neoplasm.